X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (925) 925
Publication (204) 204
Book Review (158) 158
Conference Proceeding (19) 19
Book Chapter (9) 9
Magazine Article (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
varenicline (803) 803
index medicus (623) 623
humans (468) 468
pharmacology & pharmacy (430) 430
male (362) 362
smoking cessation (348) 348
nicotine (296) 296
smoking-cessation (261) 261
female (257) 257
smoking cessation - methods (257) 257
receptor partial agonist (248) 248
animals (236) 236
smoking (226) 226
neurosciences (208) 208
psychiatry (208) 208
adult (207) 207
sustained-release bupropion (193) 193
nicotinic agonists - pharmacology (182) 182
middle aged (176) 176
smoking cessation programs (175) 175
benzazepines - therapeutic use (168) 168
quinoxalines - therapeutic use (165) 165
benzazepines - pharmacology (154) 154
quinoxalines - pharmacology (152) 152
nicotinic agonists - therapeutic use (151) 151
article (150) 150
randomized controlled-trial (148) 148
bupropion (142) 142
rats (141) 141
pharmacology (121) 121
treatment outcome (119) 119
benzazepines - adverse effects (115) 115
quinoxalines - adverse effects (115) 115
tobacco (112) 112
dose-response relationship, drug (111) 111
nicotinic agonists - administration & dosage (109) 109
smokers (103) 103
efficacy (102) 102
tobacco use disorder - drug therapy (100) 100
benzazepines - administration & dosage (99) 99
nicotine replacement therapy (98) 98
quinoxalines - administration & dosage (96) 96
placebo (95) 95
substance abuse (93) 93
nicotinic agonists - adverse effects (91) 91
dependence (90) 90
partial agonist (87) 87
nicotine - pharmacology (86) 86
pharmacology/toxicology (86) 86
receptors, nicotinic - metabolism (86) 86
drug therapy (85) 85
analysis (83) 83
nicotine - administration & dosage (83) 83
alpha-4-beta-2 (81) 81
bupropion - therapeutic use (81) 81
double-blind method (81) 81
health aspects (74) 74
cessation (73) 73
addiction (72) 72
smoking - drug therapy (72) 72
young adult (71) 71
aged (69) 69
adolescent (68) 68
mice (68) 68
pharmacotherapy (67) 67
acetylcholine-receptors (66) 66
research (66) 66
drug addiction (65) 65
drugs (64) 64
double-blind (62) 62
medicine & public health (60) 60
varenicline - pharmacology (60) 60
care and treatment (59) 59
receptors, nicotinic - drug effects (59) 59
varenicline - therapeutic use (57) 57
cigarette-smoking (55) 55
dopamine (55) 55
rats, sprague-dawley (55) 55
clinical trials (54) 54
risk factors (53) 53
biomedicine (51) 51
smoking prevention (51) 51
cytisine (50) 50
nicotine dependence (48) 48
nicotinic acetylcholine-receptors (48) 48
alcohol (47) 47
psychopharmacology (46) 46
nicotinic antagonists - pharmacology (45) 45
schizophrenia (45) 45
smoking - psychology (45) 45
tobacco use cessation products (45) 45
self administration (44) 44
safety (42) 42
smoking cessation - psychology (42) 42
abstinence (40) 40
rodents (40) 40
smoking cessation products (40) 40
clinical neurology (39) 39
depression (39) 39
reinforcement (39) 39
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (922) 922
German (9) 9
Czech (2) 2
French (2) 2
Japanese (2) 2
Polish (2) 2
Spanish (2) 2
Turkish (2) 2
Danish (1) 1
Finnish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
by Booth, R and Kim, H
Annals of Biomedical Engineering, ISSN 0090-6964, 12/2014, Volume 42, Issue 12, pp. 2379 - 2391
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 12/2010, Volume 335, Issue 3, pp. 807 - 816
Accumulating evidence suggests that acetylcholine nicotinic systems may contribute importantly to the abuse-related effects of d-methamphetamine (d-MA). The... 
DIHYDRO-BETA-ERYTHROIDINE | ACETYLCHOLINE-RECEPTORS | SQUIRREL-MONKEYS | DOPAMINE RELEASE | BEHAVIORAL SENSITIZATION | PHARMACOLOGY & PHARMACY | MONOAMINE TRANSPORTERS | STIMULUS PROPERTIES | ALPHA-BUNGAROTOXIN | NUCLEUS-ACCUMBENS | UPTAKE INHIBITORS | Nicotinic Antagonists - administration & dosage | Cholinergic Agents - administration & dosage | Cholinergic Agents - pharmacology | Varenicline | Pentobarbital - administration & dosage | Pentobarbital - pharmacology | Male | Nicotinic Antagonists - pharmacology | Dose-Response Relationship, Drug | Quinoxalines - pharmacology | Drug Interactions | Muscarinic Antagonists - pharmacology | Discrimination (Psychology) | Mecamylamine - pharmacology | Behavior, Animal - drug effects | Nicotinic Agonists - pharmacology | Discrimination Learning | Methamphetamine - pharmacology | Dopamine Agonists - pharmacology | Mecamylamine - administration & dosage | Dextroamphetamine - pharmacology | Quinoxalines - administration & dosage | Reinforcement (Psychology) | Rats | Benzazepines - pharmacology | Rats, Sprague-Dawley | Muscarinic Antagonists - administration & dosage | Nicotinic Agonists - administration & dosage | Animals | Cholinesterase Inhibitors - administration & dosage | Cholinesterase Inhibitors - pharmacology | Methamphetamine - administration & dosage | Dopamine Agonists - administration & dosage | Conditioning, Operant | Benzazepines - administration & dosage | Dextroamphetamine - administration & dosage | Index Medicus | Behavioral Pharmacology
Journal Article
Psychopharmacology, ISSN 0033-3158, 7/2013, Volume 228, Issue 2, pp. 321 - 333
Receptor mechanisms underlying the behavioral effects of clinically used nicotinic acetylcholine receptor agonists have not been fully established.Drug... 
Drug discrimination | Neurosciences | Agonist | Varenicline | Cytisine | Efficacy | Mecamylamine | Biomedicine | Mouse | Antagonist | Dihydro-β-erythroidine | Pharmacology/Toxicology | Psychiatry | Nicotine | Dihydro-beta-erythroidine | PSYCHIATRY | PHARMACOLOGICAL CHARACTERIZATION | RATS | RECEPTOR PARTIAL AGONIST | NEUROSCIENCES | ACETYLCHOLINE-RECEPTORS | MU OPIOIDS | PHARMACOLOGY & PHARMACY | DISCRIMINATIVE STIMULUS PROPERTIES | ALPHA-4-BETA-2 | Nicotine - administration & dosage | Dihydro-beta-Erythroidine - pharmacology | Male | Nicotine - pharmacology | Dose-Response Relationship, Drug | Quinoxalines - pharmacology | Discrimination Learning - drug effects | Tobacco Use Cessation Products | Mecamylamine - pharmacology | Nicotinic Agonists - pharmacology | Quinolizines - administration & dosage | Receptors, Nicotinic - drug effects | Receptors, Nicotinic - metabolism | Alkaloids - pharmacology | Morphine - pharmacology | Quinoxalines - administration & dosage | Mice, Inbred C57BL | Quinolizines - pharmacology | Benzazepines - pharmacology | Smoking Cessation - methods | Nicotinic Agonists - administration & dosage | Animals | Alkaloids - administration & dosage | Azocines - pharmacology | Benzazepines - administration & dosage | Mice | Azocines - administration & dosage | Midazolam - pharmacology | Smoking cessation programs | Dosage and administration | Health aspects | Smoking cessation | Pharmacology | Rodents | Index Medicus | dihydro-β-erythroidine | mecamylamine | varenicline | mouse | nicotine | drug discrimination | agonist | antagonist | cytisine | efficacy
Journal Article
Alcoholism: Clinical and Experimental Research, ISSN 0145-6008, 01/2016, Volume 40, Issue 1, pp. 62 - 72
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 2015, Volume 35, Issue 8, pp. 3625 - 3643
Journal Article
Journal of Natural Products, ISSN 0163-3864, 04/2018, Volume 81, Issue 4, pp. 1029 - 1035
Phantasmidine, a rigid congener of the well-known nicotinic acetylcholine receptor agonist epibatidine, is found in the same species of poison frog (... 
CHEMISTRY, MEDICINAL | CYTISINE | RAT | NATURAL-PRODUCTS | AGONISTS | DISCOVERY | PLANT SCIENCES | EPIBATIDINE | NICOTINIC ACETYLCHOLINE-RECEPTOR | PHARMACOLOGY & PHARMACY | VARENICLINE | ANTAGONISTS | BINDING | Index Medicus
Journal Article
Journal Article